Moss Genomics offers a unique approach to health examination by utilizing stool samples to analyze an individual's health without the risk of DNA being sold to third-party pharmaceutical companies. The process is straightforward: customers send in their stool samples, and in return, they receive a comprehensive health report. This service emphasizes privacy and security, as all data is trackable on the blockchain, ensuring that personal health information remains confidential and protected.

The company’s technology focuses on providing accurate and reliable health insights derived from microbiome analysis. By examining the gut microbiome through stool samples, Moss Genomics aims to deliver valuable information that can help individuals understand their health better. This innovative approach not only prioritizes user privacy but also leverages advanced scientific methods to offer personalized health assessments based on the unique composition of an individual's microbiome.

Canada

Moss is a disrupter in the consumer healthcare space offering personalized health and gut health solutions guided by genomic data, microbiome data, and clinically validated assessments. 
Founded in 2018, Moss is a technology and healthcare integrator for personalized health and offers a comprehensive line of probiotics and nutritional supplements.

Moss Genomics

Company Details